7 I den ikke- kliniske undersøgelse var Xeomin hverken mere eller mindre immunogent end Botox, selv i doser klart over den anbefalede maksimale dosis til mennesker.
In the non-clinical study, Xeomin was not more or less immunogenic than Botox even at dose levels clearly exceeding the recommended human dose.